Borderline personality disorder

Abstract: Epidemiological and neurobiological perspectives about suicidality in borderline patients are described, highlighting how self‐destructive and seemingly suicidal acts are their “behavioral specialty.” Principles for management, including the need for a primary clinician to oversee safety, and the pros and cons of both “contracting for safety” and hospitalization are presented. Clinical material is used to illustrate an approach that involves minimal initiative to rescue by therapists, a readiness to comply with patients' wishes for protection (the principle of false submission), and very active interpretation. This approach is contrasted with those advocated by Linehan and Kernberg.

[1]  Judith Lewis Herman,et al.  Trauma and Recovery , 2015 .

[2]  J. Oldham.  Borderline personality disorder and suicidality. , 2013, The American journal of psychiatry.

[3]  G. Rücker,et al.  Psychological therapies for people with borderline personality disorder. , 2012, The Cochrane database of systematic reviews.

[4]  P. Mortensen.  EPIDEMIOLOGY , 2012, Schizophrenia Research.

[5]  T. McGlashan,et al.  Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. , 2011, Archives of general psychiatry.

[6]  J. Gunderson,et al.  Family study of borderline personality disorder and its sectors of psychopathology. , 2011, Archives of general psychiatry.

[7]  J. Maltsberger,et al.  Common Factors in Empirically Supported Treatments of Borderline Personality Disorder , 2011, Current psychiatry reports.

[8]  G. Fitzmaurice,et al.  The 10‐year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects , 2010, Acta psychiatrica Scandinavica.

[9]  T. Trull,et al.  Genetic covariance structure of the four main features of borderline personality disorder. , 2010, Journal of personality disorders.

[10]  J. Maltsberger,et al.  Strategies in treatment of suicidality: identification of common and treatment-specific interventions in empirically supported treatment manuals. , 2010, The Journal of clinical psychiatry.

[11]  P. Schuster,et al.  Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial , 2010, British Journal of Psychiatry.

[12]  M. Zimmerman,et al.  Borderline personality disorder and the misdiagnosis of bipolar disorder. , 2010, Journal of psychiatric research.

[13]  L. Siever,et al.  Parental viewpoints of trajectories to borderline personality disorder in female offspring. , 2010, Journal of personality disorders.

[14]  Randy A Sansone,et al.  Road Rage: Relationships with Borderline Personality and Driving Citations , 2010, International journal of psychiatry in medicine.

[15]  S. Shafti,et al.  Olanzapine Versus Haloperidol in the Management of Borderline Personality Disorder: A Randomized Double-Blind Trial , 2010, Journal of clinical psychopharmacology.

[16]  A. Bateman,et al.  Pharmacotherapy for borderline personality disorder: NICE guideline , 2010, British Journal of Psychiatry.

[17]  N. Dahmen,et al.  Modulatory role of the brain‐derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borderline personality disorder , 2010, Genes, brain, and behavior.

[18]  G. Rücker,et al.  Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials , 2010, British Journal of Psychiatry.

[19]  Bram Stieltjes,et al.  Reduced prefrontal and orbitofrontal gray matter in female adolescents with borderline personality disorder: Is it disorder specific? , 2010, NeuroImage.

[20]  Sophie A. Lazarus,et al.  Laboratory Induced Aggression: A Positron Emission Tomography Study of Aggressive Individuals with Borderline Personality Disorder , 2009, Biological Psychiatry.

[21]  P. Links,et al.  A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. , 2009, The American journal of psychiatry.

[22]  P. Fonagy,et al.  Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. , 2009, The American journal of psychiatry.

[23]  Daniel A. Newman,et al.  The stability of personality traits in individuals with borderline personality disorder. , 2009, Journal of abnormal psychology.

[24]  Jin Fan,et al.  Neural Correlates of the Use of Psychological Distancing to Regulate Responses to Negative Social Cues: A Study of Patients with Borderline Personality Disorder , 2009, Biological Psychiatry.

[25]  J. Smit,et al.  Implementation of outpatient schema therapy for borderline personality disorder with versus without crisis support by the therapist outside office hours: A randomized trial. , 2009, Behaviour research and therapy.

[26]  B. Grenyer,et al.  Borderline personality or complex posttraumatic stress disorder? An update on the controversy. , 2009, Harvard review of psychiatry.

[27]  G. Weniger,et al.  Reduced amygdala and hippocampus size in trauma-exposed women with borderline personality disorder and without posttraumatic stress disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[28]  N. Dahmen,et al.  The 5-HTTLPR polymorphism modulates the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder. , 2009, Journal of psychiatric research.

[29]  A. Wenzel,et al.  Volumes of the hippocampus and amygdala in patients with borderline personality disorder: a meta-analysis. , 2009, Journal of personality disorders.

[30]  T. McGlashan,et al.  Ten-year stability and latent structure of the DSM-IV schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. , 2009, Journal of abnormal psychology.

[31]  F. Gueyffier,et al.  Cognitive Therapy versus Rogerian Supportive Therapy in Borderline Personality Disorder , 2009, Psychotherapy and Psychosomatics.

[32]  M. Zanarini,et al.  A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder , 2009, International clinical psychopharmacology.

[33]  C. Schmahl,et al.  Hippocampus and amygdala volumes in patients with borderline personality disorder with or without posttraumatic stress disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[34]  Hu Cheng,et al.  Neural correlates of emotion processing in borderline personality disorder , 2009, Psychiatry Research: Neuroimaging.

[35]  Norbert Dahmen,et al.  Interaction between gene variants of the serotonin transporter promoter region (5‐HTTLPR) and catechol O‐methyltransferase (COMT) in borderline personality disorder , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  N. Dahmen,et al.  Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality Disorder , 2009, Psychopathology.

[37]  Joan M. Farrell,et al.  A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. , 2009, Journal of behavior therapy and experimental psychiatry.

[38]  J. Gunderson.  Borderline personality disorder: ontogeny of a diagnosis. , 2009, The American journal of psychiatry.

[39]  Víctor Pérez,et al.  Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial. , 2009, Behaviour research and therapy.

[40]  L. Choi-Kain,et al.  The Hypothalamic‐Pituitary‐Adrenal Axis in Borderline Personality Disorder: A Review , 2009, Harvard review of psychiatry.

[41]  F. Esposito,et al.  Amygdala Deactivation as a Neural Correlate of Pain Processing in Patients with Borderline Personality Disorder and Co-Occurrent Posttraumatic Stress Disorder , 2009, Biological Psychiatry.

[42]  I. Heuser,et al.  Clonidine Improves Hyperarousal in Borderline Personality Disorder With or Without Comorbid Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial , 2009, Journal of clinical psychopharmacology.

[43]  J. Kennedy,et al.  Serotonin genes and gene–gene interactions in borderline personality disorder in a matched case-control study , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[44]  H. Yuen,et al.  Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial , 2008, British Journal of Psychiatry.

[45]  M. Bohus,et al.  Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study , 2008, British Journal of Psychiatry.

[46]  M. Linehan,et al.  Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. , 2008, Journal of consulting and clinical psychology.

[47]  Larry J Siever,et al.  Recent advances in the biological study of personality disorders. , 2008, The Psychiatric clinics of North America.

[48]  P. Cohen,et al.  Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. , 2008, Journal of child psychology and psychiatry, and allied disciplines.

[49]  B. King-Casas,et al.  The Rupture and Repair of Cooperation in Borderline Personality Disorder , 2008, Science.

[50]  Dennis Velakoulis,et al.  Orbitofrontal, amygdala and hippocampal volumes in teenagers with first-presentation borderline personality disorder , 2008, Psychiatry Research: Neuroimaging.

[51]  Jin Fan,et al.  Frontolimbic structural changes in borderline personality disorder. , 2008, Journal of psychiatric research.

[52]  R. Gallop,et al.  Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. , 2008, The Journal of clinical psychiatry.

[53]  F. Frankenburg,et al.  A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. , 2008, Journal of personality disorders.

[54]  P. Fonagy,et al.  8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. , 2008, The American journal of psychiatry.

[55]  C. Pantelis,et al.  An MRI study of pituitary volume and parasuicidal behavior in teenagers with first-presentation borderline personality disorder , 2008, Psychiatry Research: Neuroimaging.

[56]  Stephan Arndt,et al.  Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. , 2008, The American journal of psychiatry.

[57]  B. Grant,et al.  Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. , 2008, The Journal of clinical psychiatry.

[58]  D. Puigdemont,et al.  Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. , 2008, The Journal of clinical psychiatry.

[59]  R. Gregory,et al.  A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. , 2008, Psychotherapy.

[60]  U. Ebner-Priemer,et al.  Motives for Nonsuicidal Self-Injury Among Women With Borderline Personality Disorder , 2008, The Journal of nervous and mental disease.

[61]  K. Lyons-Ruth,et al.  BPD's interpersonal hypersensitivity phenotype: a gene-environment-developmental model. , 2008, Journal of personality disorders.

[62]  R. Verheul,et al.  The economic burden of personality disorders in mental health care. , 2008, The Journal of clinical psychiatry.

[63]  C. Pantelis,et al.  Pituitary volume in teenagers with first-presentation borderline personality disorder , 2007, Psychiatry Research: Neuroimaging.

[64]  J. Ford,et al.  Current and lifetime psychiatric illness among inmates not identified as acutely mentally ill at intake in Connecticut's jails. , 2007, The journal of the American Academy of Psychiatry and the Law.

[65]  David Silbersweig,et al.  Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. , 2007, The American journal of psychiatry.

[66]  Godehard Weniger,et al.  Size abnormalities of the superior parietal cortices are related to dissociation in borderline personality disorder , 2007, Psychiatry Research: Neuroimaging.

[67]  S. Jerez,et al.  Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder. , 2007, Actas espanolas de psiquiatria.

[68]  J. Paris.  The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category. , 2007, Journal of personality disorders.

[69]  R. Kessler,et al.  DSM-IV Personality Disorders in the National Comorbidity Survey Replication , 2007, Biological Psychiatry.

[70]  A. Bulbena,et al.  Hospitalization and pharmacotherapy for borderline personality disorder in a psychiatric emergency service. , 2007, Psychiatric services.

[71]  Jin Fan,et al.  Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: An event-related fMRI study , 2007, Psychiatry Research: Neuroimaging.

[72]  L. Siever,et al.  Exaggerated Affect-Modulated Startle During Unpleasant Stimuli in Borderline Personality Disorder , 2007, Biological Psychiatry.

[73]  F. Frankenburg,et al.  The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. , 2007, The American journal of psychiatry.

[74]  T. McGlashan,et al.  Longitudinal Diagnostic Efficiency of DSM-IV Criteria for Borderline Personality Disorder: A 2-Year Prospective Study , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[75]  J. Kennedy,et al.  Monoamine oxidase A gene is associated with borderline personality disorder , 2007, Psychiatric genetics.

[76]  Kenneth N. Levy,et al.  Evaluating three treatments for borderline personality disorder: a multiwave study. , 2007, The American journal of psychiatry.

[77]  P. Tyrer,et al.  Critical developments in the assessment of personality disorder. , 2007, The British journal of psychiatry. Supplement.

[78]  M. Henry,et al.  Neuroimaging and genetics of borderline personality disorder: a review. , 2007, Journal of psychiatry & neuroscience : JPN.

[79]  S. McMain,et al.  Advances in psychotherapy of personality disorders: A research update , 2007, Current psychiatry reports.

[80]  A. Fruzzetti,et al.  Advances in interventions for families with a relative with a personality disorder diagnosis , 2007, Current psychiatry reports.

[81]  J. Gunderson,et al.  The interface between borderline personality disorder and bipolar spectrum disorders. , 2007, Comprehensive psychiatry.

[82]  T. Widiger.  Current Controversies in Nosology and Diagnosis of Personality Disorders , 2007 .

[83]  Randall Newmark,et al.  Amygdala–Prefrontal Disconnection in Borderline Personality Disorder , 2007, Neuropsychopharmacology.

[84]  D. Andress-Rothrock,et al.  Borderline Personality Disorder and Migraine , 2007, Headache.

[85]  Kenneth N. Levy,et al.  Change in attachment patterns and reflective function in a randomized control trial of transference-focused psychotherapy for borderline personality disorder. , 2006, Journal of consulting and clinical psychology.

[86]  K. Kendler,et al.  Dimensional representations of DSM-IV cluster B personality disorders in a population-based sample of Norwegian twins: a multivariate study , 2006, Psychological Medicine.

[87]  J. Hennen,et al.  Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. , 2006, Journal of personality disorders.

[88]  Peter Tyrer,et al.  The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. , 2006, Journal of personality disorders.

[89]  S. Paisley,et al.  Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. , 2006, Health technology assessment.

[90]  J. Kennedy,et al.  Association between serotonin transporter gene and borderline personality disorder. , 2006, Journal of psychiatric research.

[91]  R. Gallop,et al.  Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. , 2006, Archives of general psychiatry.

[92]  C. Dirksen,et al.  Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. , 2006, Archives of general psychiatry.

[93]  S. Bellino,et al.  Combined Treatment of Major Depression in Patients with Borderline Personality Disorder: A Comparison with Pharmacotherapy , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[94]  J. Hennen,et al.  Prediction of the 10-year course of borderline personality disorder. , 2006, The American journal of psychiatry.

[95]  P. Fonagy,et al.  Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. , 2006, The American journal of psychiatry.

[96]  Martina Piefke,et al.  Functional MRI correlates of the recall of unresolved life events in borderline personality disorder , 2006, Psychological Medicine.

[97]  F. Frankenburg,et al.  Obesity and obesity-related illnesses in borderline patients. , 2006, Journal of personality disorders.

[98]  M. Stone.  Management of borderline personality disorder: a review of psychotherapeutic approaches. , 2006, World psychiatry : official journal of the World Psychiatric Association.

[99]  C. Adams,et al.  Pharmacological interventions for people with borderline personality disorder. , 2006, The Cochrane database of systematic reviews.

[100]  J. Hennen,et al.  The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. , 2005, Journal of personality disorders.

[101]  C. Sanislow,et al.  The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. , 2005, Journal of personality disorders.

[102]  Robert L Stout,et al.  Dimensional representations of DSM-IV personality disorders: relationships to functional impairment. , 2005, The American journal of psychiatry.

[103]  C. Pariante,et al.  Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis , 2005, Biological Psychiatry.

[104]  Viola Vaccarino,et al.  Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. , 2005, Journal of affective disorders.

[105]  D. Puigdemont,et al.  Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. , 2005, The American journal of psychiatry.

[106]  E. Struening,et al.  Family connections: a program for relatives of persons with borderline personality disorder. , 2005, Family process.

[107]  T. McGlashan,et al.  Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. , 2005, The American journal of psychiatry.

[108]  G. Gabbard,et al.  Mind, brain, and personality disorders. , 2005, The American journal of psychiatry.

[109]  E. Hollander,et al.  Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. , 2005, The American journal of psychiatry.

[110]  Eva Irle,et al.  Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder , 2005, Biological Psychiatry.

[111]  G. Willemsen,et al.  Heritability of Daytime Ambulatory Blood Pressure in an Extended Twin Design , 2005, Hypertension.

[112]  J. Hennen,et al.  Axis II comorbidity of borderline personality disorder: description of 6‐year course and prediction to time‐to‐remission , 2004, Acta psychiatrica Scandinavica.

[113]  Robert L Stout,et al.  Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive–compulsive personality disorder over two years , 2004, Psychological Medicine.

[114]  R. Sansone,et al.  Fibromyalgia, borderline personality, and opioid prescription. , 2004, General hospital psychiatry.

[115]  T. McGlashan,et al.  Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. , 2004, The Journal of clinical psychiatry.

[116]  Björn Meyer,et al.  What's in a (neutral) face? Personality disorders, attachment styles, and the appraisal of ambiguous social cues. , 2004, Journal of personality disorders.

[117]  F. Frankenburg,et al.  A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. , 2004, The Journal of clinical psychiatry.

[118]  T. McGlashan,et al.  The longitudinal relationship of personality traits and disorders. , 2004, Journal of abnormal psychology.

[119]  M. Linehan,et al.  Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. , 2004, Behaviour research and therapy.

[120]  F. Woermann,et al.  Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder , 2004, Biological Psychiatry.

[121]  S. Yen,et al.  Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. , 2004, The Journal of clinical psychiatry.

[122]  Alec L. Miller,et al.  Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. , 2003, AIDS patient care and STDs.

[123]  John C Gore,et al.  Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation , 2003, Biological Psychiatry.

[124]  J. Catalan,et al.  Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study , 2003, Psychological Medicine.

[125]  C. Sanislow,et al.  Plausibility and Possible Determinants of Sudden “Remissions” in Borderline Patients , 2003, Psychiatry.

[126]  Eric Vermetten,et al.  Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder , 2003, Psychiatry Research: Neuroimaging.

[127]  W. van den Brink,et al.  Dialectical behaviour therapy for women with borderline personality disorder , 2003, British Journal of Psychiatry.

[128]  W. van den Brink,et al.  SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. , 2002, The American journal of psychiatry.

[129]  B. Martindale.  Borderline Personality Disorder: A Clinical Guide , 2002 .

[130]  T. McGlashan,et al.  TRAUMATIC EXPOSURE AND POSTTRAUMATIC STRESS DISORDER IN BORDERLINE, SCHIZOTYPAL, AVOIDANT, AND OBSESSIVE-COMPULSIVE PERSONALITY DISORDERS: FINGINGS FROM THE COLLABORATIVE LONGITUDINAL PERSONALITY DISORDERS STUDY , 2002, The Journal of nervous and mental disease.

[131]  Thomas A Widiger,et al.  The borderline diagnosis I: psychopathology, comorbidity, and personaltity structure , 2002, Biological Psychiatry.

[132]  L. Siever,et al.  The borderline diagnosis III: identifying endophenotypes for genetic studies , 2002, Biological Psychiatry.

[133]  Thomas A Widiger,et al.  The borderline diagnosis II: biology, genetics, and clinical course , 2002, Biological Psychiatry.

[134]  J. Hennen,et al.  SEVERITY OF REPORTED CHILDHOOD SEXUAL ABUSE AND ITS RELATIONSHIP TO SEVERITY OF BORDERLINE PSYCHOPATHOLOGY AND PSYCHOSOCIAL IMPAIRMENT AMONG BORDERLINE INPATIENTS , 2002, The Journal of nervous and mental disease.

[135]  L. Dimeff,et al.  Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. , 2002, Drug and alcohol dependence.

[136]  F. Frankenburg,et al.  Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. , 2002, The Journal of clinical psychiatry.

[137]  K. Phillips,et al.  Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. , 2002, Archives of general psychiatry.

[138]  Robert L Stout,et al.  Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. , 2002, The American journal of psychiatry.

[139]  M. Häusser,et al.  Neurobiology , 2001, Current Opinion in Neurobiology.

[140]  J. Paris,et al.  A 27-year follow-up of patients with borderline personality disorder. , 2001, Comprehensive psychiatry.

[141]  F. Frankenburg,et al.  Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. , 2001, The Journal of clinical psychiatry.

[142]  T. Dietrich,et al.  Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study , 2001, Biological Psychiatry.

[143]  D. Lynam,et al.  Using the five-factor model to represent the DSM-IV personality disorders: an expert consensus approach. , 2001, Journal of abnormal psychology.

[144]  S. Torgersen,et al.  The prevalence of personality disorders in a community sample. , 2001, Archives of general psychiatry.

[145]  F. Frankenburg,et al.  Treatment histories of borderline inpatients. , 2001, Comprehensive psychiatry.

[146]  L. Siever,et al.  A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. , 2001, The Journal of clinical psychiatry.

[147]  T. McGlashan,et al.  Treatment utilization by patients with personality disorders. , 2001, The American journal of psychiatry.

[148]  F. Coolidge,et al.  Heritability of personality disorders in childhood: a preliminary investigation. , 2001, Journal of personality disorders.

[149]  I. Skre,et al.  A twin study of personality disorders. , 2000, Comprehensive psychiatry.

[150]  R. Turner.  Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. , 2000 .

[151]  M. Zimmerman,et al.  Differences between clinical and research practices in diagnosing borderline personality disorder. , 1999, The American journal of psychiatry.

[152]  H Schmidt,et al.  Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. , 1999, The American journal on addictions.

[153]  Donald G. Dutton,et al.  A Comparison of Impulsive and Instrumental Subgroups of Batterers , 1998, Violence and Victims.

[154]  L. Siever,et al.  The Dexamethasone Suppression Test and Glucocorticoid Receptors in Borderline Personality Disorder , 1997, Annals of the New York Academy of Sciences.

[155]  R. Bronen,et al.  Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse—a preliminary report , 1997, Biological Psychiatry.

[156]  I. Lyoo,et al.  Family Problems and Relationships for Adults with Borderline Personality Disorder , 1997, Harvard review of psychiatry.

[157]  Streichenwein Sm,et al.  Am J Psychiatry , 1996 .

[158]  E. Marziali,et al.  A controlled trial of short-term group treatment for borderline personality disorder , 1995 .

[159]  F. Lotstra,et al.  A trial of carbamazepine in borderline personality disorder , 1994, European Neuropsychopharmacology.

[160]  M. Linehan,et al.  Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. , 1993, Archives of general psychiatry.

[161]  J. Chu,et al.  Correlates of dissociative symptomatology in patients with physical and sexual abuse histories. , 1993, Comprehensive psychiatry.

[162]  S. Southwick,et al.  Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. , 1993, The American journal of psychiatry.

[163]  J. Chu.  Empathic confrontation in the treatment of childhood abuse survivors, including a tribute to the legacy of Dr. David Caul. , 1992 .

[164]  M. Linehan,et al.  Cognitive-behavioral treatment of chronically parasuicidal borderline patients. , 1991, Archives of general psychiatry.

[165]  K. Phillips,et al.  A current view of the interface between borderline personality disorder and depression. , 1991, The American journal of psychiatry.

[166]  J. Chu,et al.  Dissociative symptoms in relation to childhood physical and sexual abuse. , 1990, The American journal of psychiatry.

[167]  P. Links,et al.  Lithium Therapy for Borderline Patients: Preliminary Findings , 1990 .

[168]  D. Westen,et al.  The borderline diagnosis in adolescents: symptoms and developmental history. , 1990, The American journal of psychiatry.

[169]  A. Frank,et al.  Transference and the vicissitudes of medication use by borderline patients. , 1989, Psychiatry.

[170]  O. Kernberg,et al.  Psychodynamic Psychotherapy Of Borderline Patients , 1989 .

[171]  J. Cornelius,et al.  Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. , 1989, Journal of clinical psychopharmacology.

[172]  D. Kupfer,et al.  Biologic markers in borderline personality disorder: a review. , 1989, The Journal of clinical psychiatry.

[173]  J. C. Perry,et al.  Childhood trauma in borderline personality disorder. , 1989, The American journal of psychiatry.

[174]  J. Fairbank,et al.  Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. , 1989 .

[175]  E. Ronningstam,et al.  Early Discontinuance of Borderline Patients from Psychotherapy , 1989, The Journal of nervous and mental disease.

[176]  M. Friedman.  Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report. , 1988, The American journal of psychiatry.

[177]  R. Cowdry,et al.  Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. , 1988, Archives of general psychiatry.

[178]  G. Adler,et al.  Borderline Psychopathology and Its Treatment , 1988 .

[179]  R. Hamer,et al.  Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. , 1986, Archives of general psychiatry.

[180]  J. Gunderson,et al.  Completed psychotherapies with borderline patients. , 1984, American journal of psychotherapy.

[181]  A. Skodol,et al.  Is there a characteristic pattern to the treatment history of clinic outpatients with borderline personality? , 1983, The Journal of nervous and mental disease.

[182]  E. Miadoková.  Genetics , 1977, Biologia Plantarum.

[183]  W. Carpenter,et al.  Five year follow-up comparison of borderline and schizophrenic patients. , 1977, Comprehensive psychiatry.

[184]  P. Graffagnino.  THE TREATMENT OF THE BORDERLINE ADOLESCENT: A DEVELOPMENTAL APPROACH , 1973 .

[185]  O. Kernberg.  A Psychoanalytic Classification of Character Pathology , 1970, Journal of the American Psychoanalytic Association.

[186]  A. Wolberg.  The borderline patient. , 1952, American journal of psychotherapy.

[187]  Juan Antonio de Prado Medina.  [The borderline personality disorder in primary care]. , 2013, Revista de enfermeria.

[188]  M. Zimmerman,et al.  Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. , 2010, The Journal of clinical psychiatry.

[189]  L. Siever,et al.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. , 2010, The American journal of psychiatry.

[190]  J. Passchier,et al.  Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. , 2010, The Journal of clinical psychiatry.

[191]  T. McGlashan,et al.  New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorders Study. , 2009, Addiction.

[192]  V. Pérez,et al.  Failure to detect an association between the serotonin transporter gene and borderline personality disorder. , 2008, Journal of psychiatric research.

[193]  E. Echeburúa,et al.  [Pathological gambling and personality disorders: a pilot-study with the MCMI-II]. , 2006, Psicothema.

[194]  C. Duggan,et al.  Psychological therapies for people with borderline personality disorder. , 2006, The Cochrane database of systematic reviews.

[195]  J. Paris.  The diagnosis of borderline personality disorder: problematic but better than the alternatives. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[196]  J. Hennen,et al.  Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. , 2004, The Journal of clinical psychiatry.

[197]  H. Nurnberg,et al.  Olanzapine versus placebo in the treatment of borderline personality disorder. , 2004, The Journal of clinical psychiatry.

[198]  P. Fonagy,et al.  Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. , 2003, The American journal of psychiatry.

[199]  F. Frankenburg,et al.  omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. , 2003, The American journal of psychiatry.

[200]  J. Guzder,et al.  Diatheses and stressors in borderline pathology of childhood: the role of neuropsychological risk and trauma. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[201]  Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. , 2001, The American journal of psychiatry.

[202]  A. Fossati,et al.  Borderline Personality Disorder and childhood sexual abuse: a meta-analytic study. , 1999, Journal of personality disorders.

[203]  C. Courtois.  Healing the incest wound : adult survivors in therapy , 1996 .

[204]  J. Gunderson,et al.  The phenomenological and conceptual interface between borderline personality disorder and PTSD. , 1993, The American journal of psychiatry.

[205]  G. Vaillant,et al.  The beginning of wisdom is never calling a patient a borderline; or, the clinical management of immature defenses in the treatment of individuals with personality disorders. , 1992, The Journal of psychotherapy practice and research.

[206]  J. Chu.  The therapeutic roller coaster : dilemmas in the treatment of childhood abuse survivors. , 1992, The Journal of psychotherapy practice and research.

[207]  P. Links,et al.  Family environment and borderline personality disorder: Development of etiologic models. , 1990 .

[208]  D. Westen,et al.  Childhood sexual and physical abuse in adult patients with borderline personality disorder. , 1990, The American journal of psychiatry.

[209]  D. Westen,et al.  Physical and sexual abuse in adolescent girls with borderline personality disorder. , 1990, The American journal of orthopsychiatry.

[210]  J. C. Perry,et al.  Psychotherapy and Psychological Trauma in Borderline Personality Disorder , 1990 .

[211]  Edward Kim.  Effective Psychotherapy With Borderline Patients , 1989 .

[212]  F. Frankenburg,et al.  Childhood experiences of borderline patients. , 1989, Comprehensive psychiatry.

[213]  J. Herman,et al.  Recovery and verification of memories of childhood sexual trauma. , 1987 .

[214]  J. M. Lamb.  The rapprochement subphase of the separation-individuation process. , 1986, Maternal-child nursing journal.

[215]  N. Leone.  Response of borderline patients to loxapine and chlorpromazine. , 1982, The Journal of clinical psychiatry.

[216]  M. Mahler.  A study of the separation-individuation process and its possible application to borderline phenomena in the psychoanalytic situation. , 1971, The Psychoanalytic study of the child.

[217]  O. Kernberg.  The treatment of patients with borderline personality organization. , 1968, The International journal of psycho-analysis.